Aclaris Therapeutics, Inc.
ACRS- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001557746
No open-market purchases or sales by Aclaris Therapeutics, Inc. insiders were filed in the last 90 days; 148 institutions reported holding it in 13F filings for Q2 2026, worth $630.0M in total; no superinvestor holds it.
Q3 2021 vs. Q2 2021
How the institutions holding Aclaris Therapeutics, Inc. changed between Q2 2021 and Q3 2021.
All holders in Q3 2021All holders in Q2 2021
| Measure | Q2 2021 | Of which not filed for Q3 2021 | Q3 2021 | Change |
|---|---|---|---|---|
| Holders | 128 | 1 | 126 | −1 |
| Shares | 56.0M | 36.6K | 56.8M | +817.7K (+1.5%) |
| Value | $983.4M | $643.0K | $1.02B | +$39.4M (+4.0%) |
1 institution that held it in Q2 2021 haven't filed for Q3 2021 yet. Not filing isn't selling, so the changes leave them out.
New holders (21)
Institutions that held Aclaris Therapeutics, Inc. at the end of Q3 2021 but not at the end of Q2 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Woodline Partners LP | 594,768 | $10.7M | 0.18% |
| Great Point Partners LLC | 500,000 | $9.00M | 2.13% |
| Jetstream Capital LLC | 140,000 | $2.52M | 2.75% |
| Allianz Asset Management GmbH | 56,840 | $1.02M | 0.00% |
| Jane Street Group, LLC | 40,720 | $733.0K | 0.00% |
| Franklin Resources Inc | 36,600 | $659.0K | 0.00% |
| AlphaCrest Capital Management LLC | 35,000 | $630.0K | 0.03% |
| SG Americas Securities, LLC | 21,012 | $378.0K | 0.00% |
| Parametric Portfolio Associates LLC | 19,773 | $356.0K | 0.00% |
| Squarepoint Ops LLC | 15,834 | $285.0K | 0.00% |
| Marshall Wace, LLP | 13,619 | $245.0K | 0.00% |
| Cherry Creek Investment Advisors, Inc. | 12,515 | $225.0K | 0.15% |
| Arizona State Retirement System | 12,084 | $218.0K | 0.00% |
| Tudor Investment Corp Et Al | 10,539 | $190.0K | 0.00% |
| Blair William & Co | 10,050 | $181.0K | 0.00% |
| Zurcher Kantonalbank (Zurich Cantonalbank) | 3,211 | $58.0K | 0.00% |
| Meeder Asset Management Inc | 2,383 | $43.0K | 0.00% |
| Macquarie Group Ltd | 1,568 | $28.0K | 0.00% |
| Quantbot Technologies LP | 765 | $13.0K | 0.00% |
| TCI Wealth Advisors, Inc. | 203 | $4.00K | 0.00% |
| Berman Capital Advisors, LLC | 170 | $3.00K | 0.00% |
Sold out (22)
Institutions that held Aclaris Therapeutics, Inc. at the end of Q2 2021 and filed for Q3 2021 without it.
| Institution | Shares, Q2 2021 | Value, Q2 2021 |
|---|---|---|
| Logos Global Management LP | 675,000 | $11.9M |
| Bridgeway Capital Management, LLC | 135,000 | $2.37M |
| Pinz Capital Management, LP | 114,835 | $2.02M |
| DAFNA Capital Management LLC | 100,000 | $1.76M |
| Monashee Investment Management LLC | 100,000 | $1.76M |
| Jefferies Group LLC | 40,063 | $703.5K |
| Old Mission Capital LLC | 37,334 | $656.0K |
| Jump Financial, LLC | 34,739 | $609.0K |
| ExodusPoint Capital Management, LP | 28,975 | $509.0K |
| Engineers Gate Manager LP | 24,532 | $431.0K |
| Dynamic Technology Lab Private Ltd | 24,061 | $422.0K |
| Boothbay Fund Management, LLC | 19,174 | $337.0K |
| Quantitative Systematic Strategies LLC | 13,658 | $240.0K |
| Trexquant Investment LP | 13,555 | $238.0K |
| Twin Securities, Inc. | 12,500 | $220.0K |
| ProShare Advisors LLC | 11,264 | $198.0K |
| Advisor Group Holdings, Inc. | 3,195 | $56.0K |
| Brown Brothers Harriman & Co | 2,588 | $45.0K |
| Point72 Hong Kong Ltd | 2,378 | $42.0K |
| Panagora Asset Management Inc | 749 | $13.0K |
| Cutler Group LP | 600 | $10.0K |
| Parallel Advisors, LLC | 100 | $2.00K |
Not filed for Q3 2021 yet (1)
Institutions that held Aclaris Therapeutics, Inc. at the end of Q2 2021 and haven't filed a 13F for Q3 2021. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q2 2021 | Value, Q2 2021 |
|---|---|---|
| QS Investors, LLC | 36,600 | $643.0K |